Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 76 Records) |
| Query Trace: Neoplasms and PBRM1[original query] |
|---|
| Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas. Cancers 2021 8 13 (15): . Glückstein Marie-Isabelle, Dintner Sebastian, Arndt Tim Tobias, Vlasenko Dmytro, Schenkirsch Gerhard, Agaimy Abbas, Müller Gernot, Märkl Bruno, Grosser Bian |
| Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Molecular genetics & genomic medicine 2021 Jun e1697. Shen Dong, Zhang Junling, Yuan Kai, Zhao Jing, Zhao Zhengyi, Cui Longgang, Zhang Yuzi, Wang Guoqiang, Cai Shangli, Bai Yuezong, Li Wei, Huang Xia |
| Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma. Cancers 2021 12 13 (24): . Sauter-Meyerhoff Carolin, Bohnert Regina, Mazzola Pascale, Stühler Viktoria, Kandabarau Siarhei, Büttner Florian A, Winter Stefan, Herrmann Lisa, Rausch Steffen, Hennenlotter Jörg, Fend Falko, Scharpf Marcus, Stenzl Arnulf, Ossowski Stephan, Bedke Jens, Schwab Matthias, Schaeffeler El |
| Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science 2021 10 113 (1): 297-307. Yoshikawa Yoshie, Yamada Yusuke, Emi Mitsuru, Atanesyan Lilit, Smout Jan, de Groot Karel, Savola Suvi, Nakanishi-Shinkai Yukako, Kanematsu Akihiro, Nojima Michio, Ohmuraya Masaki, Hashimoto-Tamaoki Tomoko, Yamamoto Shin |
| The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. European urology 2021 10 81 (2): 145-148. Hagiwara Masayuki, Fushimi Atsushi, Matsumoto Kazuhiro, Oya Mototsu |
| Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 9 35 (12): 1929-1943. Mafficini Andrea, Simbolo Michele, Shibata Tatsuhiro, Hong Seung-Mo, Pea Antonio, Brosens Lodewijk A, Cheng Liang, Antonello Davide, Sciammarella Concetta, Cantù Cinzia, Mattiolo Paola, Taormina Sergio V, Malleo Giuseppe, Marchegiani Giovanni, Sereni Elisabetta, Corbo Vincenzo, Paolino Gaetano, Ciaparrone Chiara, Hiraoka Nobuyoshi, Pallaoro Daniel, Jansen Casper, Milella Michele, Salvia Roberto, Lawlor Rita T, Adsay Volkan, Scarpa Aldo, Luchini Claud |
| Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis. Gene 2022 Aug 834 146638. Wang Nanya, Qin Yong, Du Furong, Wang Xiaoxuan, Song Ch |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Mutation spectrum associated with metastasis of advanced cholangiocarcinoma. The Journal of international medical research 2022 Jun 50 (6): 3000605221102080. Song Hao, Huang Yao, Jiang Xiaoqi |
| Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. Scientific reports 2022 4 12 (1): 6478. van de Pol Jeroen A A, Ferronika Paranita, Westers Helga, van Engeland Manon, Terpstra Martijn M, Smits Kim M, de Lange Kim, van den Brandt Piet A, Sijmons Rolf H, Schouten Leo J, Kok Kla |
| Establishing a Prognostic Model Based on Three Genomic Instability-related LncRNAs for Clear Cell Renal Cell Cancer. Clinical genitourinary cancer 2022 3 20 (4): e317-e329. Lulu Shen, Hualing Hou, Shan Zhang, Dianxi Chen, Yiqing Li, Qin |
| Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma. Nature cancer 2022 2 1 (6): 635-652. Alkallas Rached, Lajoie Mathieu, Moldoveanu Dan, Hoang Karen Vo, Lefrançois Philippe, Lingrand Marine, Ahanfeshar-Adams Mozhdeh, Watters Kevin, Spatz Alan, Zippin Jonathan H, Najafabadi Hamed S, Watson Ian |
| Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma. Gynecologic oncology 2022 Feb . Liao Xin, Xia Xuyang, Su Wei, Yan Huayun, Ma Yingfang, Xu Lian, Luo Han, Liu Wanting, Yin Dandan, Zhang Wei-Han, Chen Hai-Ning, Deng Yiqi, Ren Zhixiang, Yu Zehui, Liao Fei, Chen Keling, Cao Minyuan, Zhang Yiguan, Zhang Wei, Wang Wei, Zhao Jun-Ning, Xu Heng, Shu Ya |
| Non?small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB. Scientific reports 2022 12 12 (1): 20734. Miao Xia-Ye, Wu Hao, Ye Bi-Cheng, Yi Qian-Wen, Lin Fang-Nan, Wang Yi-Lin, Ren Chuan-Li, Jiang Yan-Fang, Li A |
| Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer medicine 2022 11 . Li Kai, Cao Li, Li Cheukfai, Wu Jundong, Chen Bo, Zhang Guochun, Li Xueri, Wen Lingzhu, Jia Minghan, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Mok Hsiaopei, Ren Chongyang, Wang Yulei, Qi Xiaofang, Guo Lijie, Che Yue, Liao Ni |
| SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases. Cancer cell international 2022 11 22 (1): 347. Li Yue, Yang Xinhua, Zhu Weijie, Xu Yuxia, Ma Jiangjun, He Caiyun, Wang Fa |
| T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 2022 1 11 (1): 1993042. Lee Moon Hee, Järvinen Petrus, Nísen Harry, Brück Oscar, Ilander Mette, Uski Ilona, Theodoropoulos Jason, Kankainen Matti, Mirtti Tuomas, Mustjoki Satu, Kreutzman An |
| Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively. Annals of surgery 2022 Aug . Bencivenga Maria, Simbolo Michele, Ciaparrone Chiara, Vicentini Caterina, Torroni Lorena, Piredda Maria Liliana, Sacco Michele, Alloggio Mariella, Castelli Claudia, Tomezzoli Anna, Scarpa Aldo, De Manzoni Giovan |
| Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
| PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer. American journal of cancer research 2023 6 13 (5): 2116-2125. María Santos, Javier Lanillos, Eduardo Caleiras, Carlos Valdivia, Juan M Roldan-Romero, Nuria Laínez, Javier Puente, Benoit Beuselinck, Stéphane Oudard, Jessica Zucman-Rossi, Paloma Navarro, Mercedes Robledo, Daniel Castellano, Guillermo de Velasco, Jesús García-Donas, Cristina Rodriguez-Anto |
| Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis. Revista da Associacao Medica Brasileira (1992) 2023 5 69 (5): e20220415. Emin Demirel, Okan Dil |
| PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers. Frontiers in genetics 2023 1 13 1066347. Dai Jiali, Cui Yanan, Liang Xiao, Xu Jiali, Li Jun, Chen Yu, Zhang Erbao, Guo Renh |
| Differences in mutations across tumour sizes in clear-cell renal cell carcinoma. BJU international 2024 9 . Steven M Monda, Benjamin W Carney, Allison M May, Shuchi Gulati, Simpa S Salami, Thenappan Chandrasekar, Evan T Keller, Nicolai A Huebner, Ganesh S Palapattu, Marc A Dall'E |
| Genomic profiles and clinical presentation of chordoma. Acta neuropathologica communications 2024 8 12 (1): 129. Hela Koka, Weiyin Zhou, Mary L McMaster, Jiwei Bai, Wen Luo, Alyssa Klein, Tongwu Zhang, Xing Hua, Xin Li, Difei Wang, Yujia Xiong, Kristine Jones, Aurelie Vogt, Belynda Hicks, Dilys Parry, Alisa M Goldstein, Xiaohong R Ya |
| Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma. Journal of the National Cancer Center 2024 7 3 (3): 236-249. Aihetaimujiang Anwaier, Wenhao Xu, Wangrui Liu, Shiyin Wei, Xi Tian, Yuanyuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei |
| Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics. Heliyon 2024 6 10 (11): e31816. Ruizhi Gao, Jinshu Pang, Peng Lin, Rong Wen, Dongyue Wen, Yiqiong Liang, Zhen Ma, Li Liang, Yun He, Hong Ya |
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 2024 6 12 918. Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortz |
| Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers 2024 5 16 (10): . Corbin J Eule, Junxiao Hu, Dale Hedges, Alkesh Jani, Thomas Pshak, Brandon J Manley, Alejandro Sanchez, Robert Dreicer, Zin W Myint, Yousef Zakharia, Elaine T L |
| Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 . Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voe |
| Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities. Frontiers in immunology 2024 11 15 1423796. Yuting Li, Qinghua Wang, Xiaopan Gao, Jinyang Zheng, Wenjing Zhang, Yanfeng Ren, Wei Shen, Wei Su, Ping |
- Page last reviewed:Feb 1, 2024
- Content source: